CF PharmTech, Inc. (HKG:2652)

CF PharmTech Statistics

Total Valuation

CF PharmTech has a market cap or net worth of HKD 8.04 billion. The enterprise value is 7.48 billion.

Market Cap	8.04B
Enterprise Value	7.48B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

CF PharmTech has 411.03 million shares outstanding. The number of shares has increased by 1.85% in one year.

Current Share Class	301.27M
Shares Outstanding	411.03M
Shares Change (YoY)	+1.85%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	9.18%
Float	225.78M

Valuation Ratios

The trailing PE ratio is 2,908.80.

PE Ratio	2,908.80
Forward PE	n/a
PS Ratio	16.71
PB Ratio	4.92
P/TBV Ratio	5.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2,703.30
EV / Sales	15.53
EV / EBITDA	201.27
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.10.

Current Ratio	4.59
Quick Ratio	4.23
Debt / Equity	0.10
Debt / EBITDA	4.34
Debt / FCF	n/a
Interest Coverage	-7.93

Financial Efficiency

Return on equity (ROE) is 0.21% and return on invested capital (ROIC) is -0.96%.

Return on Equity (ROE)	0.21%
Return on Assets (ROA)	-0.83%
Return on Invested Capital (ROIC)	-0.96%
Return on Capital Employed (ROCE)	-1.27%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	795,560
Profits Per Employee	4,571
Employee Count	605
Asset Turnover	0.28
Inventory Turnover	2.49

Taxes

Income Tax	-17.68M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.74
200-Day Moving Average	n/a
Relative Strength Index (RSI)	29.63
Average Volume (20 Days)	455,165

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CF PharmTech had revenue of HKD 481.31 million and earned 2.77 million in profits. Earnings per share was 0.01.

Revenue	481.31M
Gross Profit	364.93M
Operating Income	-22.42M
Pretax Income	-14.92M
Net Income	2.77M
EBITDA	37.33M
EBIT	-22.42M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 730.25 million in cash and 161.98 million in debt, with a net cash position of 568.27 million or 1.38 per share.

Cash & Cash Equivalents	730.25M
Total Debt	161.98M
Net Cash	568.27M
Net Cash Per Share	1.38
Equity (Book Value)	1.63B
Book Value Per Share	3.97
Working Capital	774.73M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	61.92M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 75.82%, with operating and profit margins of -4.66% and 0.57%.

Gross Margin	75.82%
Operating Margin	-4.66%
Pretax Margin	-3.10%
Profit Margin	0.57%
EBITDA Margin	7.76%
EBIT Margin	-4.66%
FCF Margin	n/a

Dividends & Yields

CF PharmTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.85%
Shareholder Yield	-1.85%
Earnings Yield	0.03%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2